The ETP Nanomedicine and its partners organize the 2nd Nano World Cancer Day
30 January 2014 - 31 January 2014
Austria
Berlin, Germany, January 28th, 2013 – The European Platform of Nanomedicine (ETPN) and its partners will organize a pan-European event on January 30-31st on
“Nanomedicine for cancer … did you know? An event shedding light”
The Nano World Cancer Day is an annual pan-European event happening in the framework of the World Cancer Day (February 4th) and under the aegis of the ETPN. Beneficiating from the media coverage of the World Cancer Day, these simultaneous press conferences are a chance to raise awareness and improve knowledge about the field of nanomedicine and its range of applications against cancer, from diagnostic to therapeutic perspectives.
For 2014, 13 countries already gave their engagement to set up a national event, highlighting the importance of nanomedicine research for cancer on the European level: in Austria, Czech Republic, Finland, France, Germany, Greece, Italy, Ireland, Luxembourg, Netherlands, Norway, Portugal, United Kingdom.
“We are extremely pleased with the growing success of the concept, where within one year we moved from 03 to 13 countries across Europe: the Nano World Cancer Day is now sustainably established”, said Nicolas Gouze, from the ETPN Secretariat. “It is an outstanding opportunity to highlight local nanomedicine resources and initiatives while federating the overall community across Europe working for a common good and better health, starting with cancer. All local organizers should be thanked for their significant contribution to the success and visibility of this second edition”.
Building on the success of last year's edition, Nano World Cancer Day 2014 will focus on the four following themes:
1) Cancer today: what is at stake
2) Nanomedicine for cancer: what it is and how it works
3) Nanomedicine is already a reality for patients
4) Yes, we can make it happen faster
Leading experts across Europe and from all categories of stakeholders will take part in shedding light on Nanomedicine and Cancer:
National organization: BioNanoNet & Techkonnex (AT), Hellenic Pharmaceutical Society (EL), Fondazione Don Carlo Gnocchi ONLUS (IT) – Istituto Nazionale dei Tumori (IT), Oslo Cancer Cluster (NO), Norwegian Cancer Society (NO), International Iberian Nanotechnology Laboratory (PT)
SMEs / Pharma: AstraZeneca (UK), Guerbet (FR), Philips Technology GmbH (DE), Nanobiotix (FR), BioAlliance Pharma (FR), NanoSurf (AT), Cellix Ltd (IE), Cybernano (LU), PCI Biotech (NO), Endomagnetics (UK), Oncos Therapeutics (FI), Orion Pharma (FI), To-BBB (NL), Tagworks Pharmaceuticals (NL)
Hospitals/Clinical organizations: Comprehensive Cancer Center (Charité University Hospital) (DE), Masaryk Oncology Institute (CZ), oncology clinic/Thomayerovy Hospital (CZ), Clinique Hartmann (FR), St. James's Hospital (IE), School of Medicine, TCD (IE), Oslo University Hospital (NO), Medizinische Universitaet Graz (AT), Universitätsklinikum Erlangen (DE), Fondazione IRCCS Istituto Neurologico Besta, IFOM - FIRC Institute of Molecular Oncology (IT), Centre Hospitalier Luxembourg (LU), Hospital Clinico de Santiago de Compostela (PT)
Universities / Public laboratory: Technology Centre ASCR (CZ), Institute for Molecular Psychiatry of Bonn University (DE), Institute for Process Engineering Pharmaceutical and Process Engineering Graz University of Technology (AT), University of Graz (AT), Lundbeckfonden Center(DE), Athens University (EL), Technological Educational Institute of Athens (EL), Trinity College Dublin, School of Medicine (IE), Fondazione San Raffaele del Monte Tabor (IT), Università di Milano-Bicocca (IT), Centre Gabriel Lippmann (LU), Nancy University (LU), BSNM-University of Liverpool (UK), University of Helsinki, Faculty of Pharmacy and Centre for Drug Research (FI), Radboud University Nijmegen (NL), Institute of Chemical Technology (CZ), Academy of Sciences of the Czech Republic (CZ), Instituto Português de Oncologia do Porto ( IPOP) (PT), INEB, University of Porto (PT)
This second edition of the Nano World Cancer day is organized in parallel of a series of initiatives launched under NANOMED2020 like the Nanomedicine Awards and the European Nanomed Map. These initiatives were launched to structure the European landscape and promote the field of nanomedicine to both the general public and all stakeholders involved in such ecosystem.
“Nanomedicine for cancer … did you know? An event shedding light”
The Nano World Cancer Day is an annual pan-European event happening in the framework of the World Cancer Day (February 4th) and under the aegis of the ETPN. Beneficiating from the media coverage of the World Cancer Day, these simultaneous press conferences are a chance to raise awareness and improve knowledge about the field of nanomedicine and its range of applications against cancer, from diagnostic to therapeutic perspectives.
For 2014, 13 countries already gave their engagement to set up a national event, highlighting the importance of nanomedicine research for cancer on the European level: in Austria, Czech Republic, Finland, France, Germany, Greece, Italy, Ireland, Luxembourg, Netherlands, Norway, Portugal, United Kingdom.
“We are extremely pleased with the growing success of the concept, where within one year we moved from 03 to 13 countries across Europe: the Nano World Cancer Day is now sustainably established”, said Nicolas Gouze, from the ETPN Secretariat. “It is an outstanding opportunity to highlight local nanomedicine resources and initiatives while federating the overall community across Europe working for a common good and better health, starting with cancer. All local organizers should be thanked for their significant contribution to the success and visibility of this second edition”.
Building on the success of last year's edition, Nano World Cancer Day 2014 will focus on the four following themes:
1) Cancer today: what is at stake
2) Nanomedicine for cancer: what it is and how it works
3) Nanomedicine is already a reality for patients
4) Yes, we can make it happen faster
Leading experts across Europe and from all categories of stakeholders will take part in shedding light on Nanomedicine and Cancer:
National organization: BioNanoNet & Techkonnex (AT), Hellenic Pharmaceutical Society (EL), Fondazione Don Carlo Gnocchi ONLUS (IT) – Istituto Nazionale dei Tumori (IT), Oslo Cancer Cluster (NO), Norwegian Cancer Society (NO), International Iberian Nanotechnology Laboratory (PT)
SMEs / Pharma: AstraZeneca (UK), Guerbet (FR), Philips Technology GmbH (DE), Nanobiotix (FR), BioAlliance Pharma (FR), NanoSurf (AT), Cellix Ltd (IE), Cybernano (LU), PCI Biotech (NO), Endomagnetics (UK), Oncos Therapeutics (FI), Orion Pharma (FI), To-BBB (NL), Tagworks Pharmaceuticals (NL)
Hospitals/Clinical organizations: Comprehensive Cancer Center (Charité University Hospital) (DE), Masaryk Oncology Institute (CZ), oncology clinic/Thomayerovy Hospital (CZ), Clinique Hartmann (FR), St. James's Hospital (IE), School of Medicine, TCD (IE), Oslo University Hospital (NO), Medizinische Universitaet Graz (AT), Universitätsklinikum Erlangen (DE), Fondazione IRCCS Istituto Neurologico Besta, IFOM - FIRC Institute of Molecular Oncology (IT), Centre Hospitalier Luxembourg (LU), Hospital Clinico de Santiago de Compostela (PT)
Universities / Public laboratory: Technology Centre ASCR (CZ), Institute for Molecular Psychiatry of Bonn University (DE), Institute for Process Engineering Pharmaceutical and Process Engineering Graz University of Technology (AT), University of Graz (AT), Lundbeckfonden Center(DE), Athens University (EL), Technological Educational Institute of Athens (EL), Trinity College Dublin, School of Medicine (IE), Fondazione San Raffaele del Monte Tabor (IT), Università di Milano-Bicocca (IT), Centre Gabriel Lippmann (LU), Nancy University (LU), BSNM-University of Liverpool (UK), University of Helsinki, Faculty of Pharmacy and Centre for Drug Research (FI), Radboud University Nijmegen (NL), Institute of Chemical Technology (CZ), Academy of Sciences of the Czech Republic (CZ), Instituto Português de Oncologia do Porto ( IPOP) (PT), INEB, University of Porto (PT)
This second edition of the Nano World Cancer day is organized in parallel of a series of initiatives launched under NANOMED2020 like the Nanomedicine Awards and the European Nanomed Map. These initiatives were launched to structure the European landscape and promote the field of nanomedicine to both the general public and all stakeholders involved in such ecosystem.